Guidance: Actions to contain carbapenemase-producing Enterobacterales (CPE)

Public Health England

October 1
15:30 2020

Framework of actions to contain carbapenemase-producing Enterobacterales

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email tell us what format you need. It will help us if you say what assistive technology you use.


The increased incidence of carbapenemase-producing Enterobacterales (CPE) has significant cost and operational implications for healthcare providers.

Unless action is taken and we learn from experiences elsewhere in the world, rapid spread of CPE will pose an ever-increasing threat to public health and medical treatment pathways in the UK.

The framework sets out a range of measures, that if implemented well, will help health and social care providers minimise the impact of CPE.

Published 1 October 2020

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: